Name | Number of supported studies | Average coverage | |
---|---|---|---|
transit amplifying cell | 3 studies | 35% ± 11% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
liver | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
uterus | 100% | 386.88 | 170 / 170 | 100% | 18.52 | 458 / 459 |
bladder | 100% | 469.29 | 21 / 21 | 99% | 14.71 | 499 / 504 |
breast | 100% | 394.15 | 457 / 459 | 99% | 10.84 | 1108 / 1118 |
ovary | 100% | 649.39 | 180 / 180 | 98% | 11.08 | 423 / 430 |
lung | 99% | 417.25 | 574 / 578 | 97% | 15.03 | 1125 / 1155 |
intestine | 99% | 430.01 | 958 / 966 | 97% | 13.25 | 510 / 527 |
esophagus | 98% | 404.50 | 1417 / 1445 | 98% | 9.61 | 179 / 183 |
stomach | 99% | 300.87 | 356 / 359 | 96% | 11.95 | 274 / 286 |
skin | 100% | 626.93 | 1804 / 1809 | 94% | 9.41 | 446 / 472 |
thymus | 100% | 395.32 | 653 / 653 | 92% | 7.33 | 557 / 605 |
prostate | 100% | 454.94 | 245 / 245 | 80% | 3.80 | 403 / 502 |
kidney | 100% | 293.10 | 89 / 89 | 75% | 4.62 | 672 / 901 |
liver | 98% | 271.36 | 222 / 226 | 74% | 6.49 | 300 / 406 |
pancreas | 74% | 120.14 | 244 / 328 | 89% | 6.41 | 159 / 178 |
adrenal gland | 100% | 517.41 | 258 / 258 | 27% | 3.09 | 61 / 230 |
lymph node | 0% | 0 | 0 / 0 | 100% | 19.04 | 29 / 29 |
spleen | 100% | 708.11 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 17.77 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 5.56 | 1 / 1 |
adipose | 97% | 332.44 | 1172 / 1204 | 0% | 0 | 0 / 0 |
brain | 49% | 68.22 | 1290 / 2642 | 47% | 3.28 | 332 / 705 |
blood vessel | 92% | 220.51 | 1230 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 78% | 391.87 | 725 / 929 | 0% | 0 | 0 / 0 |
heart | 77% | 170.33 | 665 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 57% | 2.77 | 46 / 80 |
muscle | 24% | 35.76 | 196 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042176 | Biological process | regulation of protein catabolic process |
GO_0044773 | Biological process | mitotic DNA damage checkpoint signaling |
GO_0006302 | Biological process | double-strand break repair |
GO_0006974 | Biological process | DNA damage response |
GO_0042771 | Biological process | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator |
GO_0006978 | Biological process | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator |
GO_0090399 | Biological process | replicative senescence |
GO_0051301 | Biological process | cell division |
GO_0070242 | Biological process | thymocyte apoptotic process |
GO_0071480 | Biological process | cellular response to gamma radiation |
GO_0090307 | Biological process | mitotic spindle assembly |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0050821 | Biological process | protein stabilization |
GO_0008630 | Biological process | intrinsic apoptotic signaling pathway in response to DNA damage |
GO_1901796 | Biological process | regulation of signal transduction by p53 class mediator |
GO_2000785 | Biological process | regulation of autophagosome assembly |
GO_0006355 | Biological process | regulation of DNA-templated transcription |
GO_0030163 | Biological process | protein catabolic process |
GO_0006977 | Biological process | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest |
GO_0000086 | Biological process | G2/M transition of mitotic cell cycle |
GO_0031573 | Biological process | mitotic intra-S DNA damage checkpoint signaling |
GO_0006468 | Biological process | protein phosphorylation |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0042770 | Biological process | signal transduction in response to DNA damage |
GO_0000077 | Biological process | DNA damage checkpoint signaling |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0016605 | Cellular component | PML body |
GO_0005737 | Cellular component | cytoplasm |
GO_0000781 | Cellular component | chromosome, telomeric region |
GO_0005634 | Cellular component | nucleus |
GO_0042803 | Molecular function | protein homodimerization activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0019901 | Molecular function | protein kinase binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0031625 | Molecular function | ubiquitin protein ligase binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0046872 | Molecular function | metal ion binding |
GO_0005524 | Molecular function | ATP binding |
GO_0005515 | Molecular function | protein binding |
Gene name | CHEK2 |
Protein name | Truncated checkpoint kinase 2 Serine/threonine-protein kinase Chk2 (EC 2.7.11.1) (CHK2 checkpoint homolog) (Cds1 homolog) (Hucds1) (hCds1) (Checkpoint kinase 2) Serine/threonine-protein kinase Chk2 [hydroxymethylglutaryl-CoA reductase (NADPH)] kinase (EC 2.7.11.31) (Acetyl-CoA carboxylase kinase) (Hydroxymethylglutaryl-CoA reductase kinase) Checkpoint kinase 2 |
Synonyms | RAD53 CDS1 CHK2 |
Description | FUNCTION: Serine/threonine-protein kinase which is required for checkpoint-mediated cell cycle arrest, activation of DNA repair and apoptosis in response to the presence of DNA double-strand breaks. May also negatively regulate cell cycle progression during unperturbed cell cycles. Following activation, phosphorylates numerous effectors preferentially at the consensus sequence [L-X-R-X-X-S/T]. Regulates cell cycle checkpoint arrest through phosphorylation of CDC25A, CDC25B and CDC25C, inhibiting their activity. Inhibition of CDC25 phosphatase activity leads to increased inhibitory tyrosine phosphorylation of CDK-cyclin complexes and blocks cell cycle progression. May also phosphorylate NEK6 which is involved in G2/M cell cycle arrest. Regulates DNA repair through phosphorylation of BRCA2, enhancing the association of RAD51 with chromatin which promotes DNA repair by homologous recombination. Also stimulates the transcription of genes involved in DNA repair (including BRCA2) through the phosphorylation and activation of the transcription factor FOXM1. Regulates apoptosis through the phosphorylation of p53/TP53, MDM4 and PML. Phosphorylation of p53/TP53 at 'Ser-20' by CHEK2 may alleviate inhibition by MDM2, leading to accumulation of active p53/TP53. Phosphorylation of MDM4 may also reduce degradation of p53/TP53. Also controls the transcription of pro-apoptotic genes through phosphorylation of the transcription factor E2F1. Tumor suppressor, it may also have a DNA damage-independent function in mitotic spindle assembly by phosphorylating BRCA1. Its absence may be a cause of the chromosomal instability observed in some cancer cells. Promotes the CCAR2-SIRT1 association and is required for CCAR2-mediated SIRT1 inhibition . .; FUNCTION: (Microbial infection) Phosphorylates herpes simplex virus 1/HHV-1 protein ICP0 and thus activates its SUMO-targeted ubiquitin ligase activity. . |
Accessions | ENST00000649563.1 [O96017-13] ENST00000425190 ENST00000439200.5 O96017 ENST00000434810.5 ENST00000711048.1 ENST00000456369.5 A0A7P0MUT5 ENST00000650281.1 [O96017-1] B7ZBF2 ENST00000403642.5 [O96017-4] ENST00000348295.7 [O96017-12] ENST00000405598.5 [O96017-1] H7C0V7 A0A3B3ITA7 H0Y4V6 H7BZ30 ENST00000464581.6 H0Y820 ENST00000425190.7 [O96017-13] ENST00000448511.5 [O96017-6] B7ZBF7 ENST00000439346.5 C9JFD7 ENST00000439346.6 [O96017-5] ENST00000416671.5 A0A4P8PR71 ENST00000404276.6 [O96017-1] ENST00000417588.5 [O96017-5] ENST00000433728.5 [O96017-8] F8WCV2 ENST00000398017.3 A0A087X102 A0A4V1ES41 A0AA34QVK6 ENST00000433028.6 ENST00000402731.6 B7ZBF8 ENST00000382580.6 [O96017-9] ENST00000454252.2 ENST00000650233.1 |